Holen Sie sich die Stockscreener-App
3.63
1.29%
0.03
Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten
In the Green: Relay Therapeutics Inc (RLAY) Closes at 3.06, Up/Down -6.42 from Previous Day - DWinneX
Relay Therapeutics’ SWOT analysis: AI-driven drug discovery stock faces pivotal phase - Investing.com India
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by California State Teachers Retirement System - Defense World
Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors | RLAY Stock News - GuruFocus
Relay Therapeutics Appoints Claire Mazumdar to Board of Directors - citybiz
# Relay Therapeutics appoints Bicara CEO to board ahead of breast cancer trial - Investing.com India
# Relay Therapeutics appoints Bicara CEO to board ahead of breast cancer trial By Investing.com - Investing.com South Africa
Relay Therapeutics Appoints Claire Mazumdar To Board Of Directors - MarketScreener
Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors - Bluefield Daily Telegraph
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 9,293 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Relay Therapeutics, Inc. (RLAY): A Bull Case Theory - Insider Monkey
Relay Therapeutics Holds 2025 Annual Stockholder Meeting - TipRanks
Layoff Tracker: Capsida Downsizes as Part of Shift to Clinical-Stage Company - BioSpace
Relay Therapeutics (RLAY) Gets a Hold from Wells Fargo - The Globe and Mail
Relay Therapeutics Announces Lease Termination Agreement - TipRanks
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Sold by Bank of America Corp DE - Defense World
Citizens JMP maintains Relay Therapeutics stock rating after trial data By Investing.com - Investing.com Canada
Nuveen Asset Management LLC Increases Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Jane Street Group LLC Cuts Stock Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics reports promising breast cancer drug data By Investing.com - Investing.com South Africa
Relay Therapeutics’ RLY-2608 Shows Promising 11-Month PFS in Breast Cancer - Insider Monkey
Relay Therapeutics, Inc. Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival At Asco 2025 - MarketScreener
Relay Therapeutics (RLAY) Shares Positive Interim Results for RL - GuruFocus
Relay Therapeutics reports promising breast cancer drug data - Investing.com Australia
Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025 | RLAY Stock News - GuruFocus
Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025 - TradingView
Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock Position Lifted by ProShare Advisors LLC - Defense World
Deutsche Bank AG Purchases 30,278 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Ameriprise Financial Inc. Purchases 28,989 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 17,009 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June - The Manila Times
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June | RLAY Stock News - GuruFocus
Relay Therapeutics Management to Share Latest Precision Medicine Strategy at Two Major Healthcare Conferences - Stock Titan
Relay Therapeutics’ SWOT analysis: ai-driven biotech stock faces pivotal year - Investing.com Nigeria
Healthcare's Quiet AI Boom Is Creating a New Class of Breakout Contenders - Quantisnow
Healthcare's Quiet AI Boom Is Creating a New Class of Breakout Contenders – Company Announcement - Financial Times
Man Group plc Buys Shares of 173,605 Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
What Makes Relay Therapeutics (RLAY) a New Buy Stock - MSN
Northern Trust Corp Buys 231,713 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
BNP Paribas Financial Markets Invests $987,000 in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Stifel Financial Corp Makes New Investment in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Transcript : Relay Therapeutics, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 03 - marketscreener.com
Relay Therapeutics, Inc. (RLAY): One of the Best Low Priced Biotech Stocks to Buy Now - Yahoo Finance
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):